DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,716,729 | +10.8% | 14,980,765 | +7.2% | 0.54% | +16.7% |
Q2 2023 | $3,354,441 | -17.1% | 13,976,829 | -12.9% | 0.47% | -22.9% |
Q1 2023 | $4,045,891 | -17.0% | 16,052,568 | -12.6% | 0.61% | -22.7% |
Q4 2022 | $4,875,202 | -99.9% | 18,367,876 | -10.7% | 0.78% | -10.3% |
Q3 2022 | $5,334,211,000 | -20.4% | 20,557,522 | -22.3% | 0.87% | +3.2% |
Q2 2022 | $6,703,917,000 | -18.6% | 26,443,349 | -5.9% | 0.85% | +1.9% |
Q1 2022 | $8,240,226,000 | -9.3% | 28,092,001 | +1.8% | 0.83% | +1.7% |
Q4 2021 | $9,083,349,000 | +4.8% | 27,608,122 | -3.0% | 0.82% | +0.1% |
Q3 2021 | $8,669,047,000 | +1.0% | 28,475,387 | -11.0% | 0.82% | +2.6% |
Q2 2021 | $8,581,329,000 | +18.6% | 31,976,932 | -0.5% | 0.80% | +9.8% |
Q1 2021 | $7,234,975,000 | +4.0% | 32,144,018 | +2.5% | 0.72% | +1.4% |
Q4 2020 | $6,959,435,000 | -8.4% | 31,358,000 | -11.1% | 0.71% | -18.8% |
Q3 2020 | $7,597,153,000 | +14.4% | 35,281,446 | -6.0% | 0.88% | +5.3% |
Q2 2020 | $6,640,368,000 | +21.0% | 37,552,265 | -5.3% | 0.84% | -3.8% |
Q1 2020 | $5,486,142,000 | -11.2% | 39,636,890 | -1.6% | 0.87% | +8.4% |
Q4 2019 | $6,181,408,000 | +5.8% | 40,275,007 | -0.4% | 0.80% | -3.1% |
Q3 2019 | $5,842,141,000 | +4.7% | 40,449,631 | +3.6% | 0.83% | +5.5% |
Q2 2019 | $5,580,042,000 | +11.3% | 39,043,116 | +2.8% | 0.78% | +6.4% |
Q1 2019 | $5,015,595,000 | +42.2% | 37,991,177 | +11.0% | 0.74% | +23.5% |
Q4 2018 | $3,528,087,000 | +10.8% | 34,213,419 | +16.7% | 0.60% | +28.4% |
Q3 2018 | $3,184,932,000 | -14.9% | 29,310,987 | -22.7% | 0.46% | -18.7% |
Q2 2018 | $3,741,168,000 | -13.5% | 37,912,122 | -14.2% | 0.57% | -16.7% |
Q1 2018 | $4,324,183,000 | +3.9% | 44,164,871 | -1.5% | 0.69% | +1.8% |
Q4 2017 | $4,160,261,000 | +9.9% | 44,820,738 | +1.6% | 0.68% | +4.5% |
Q3 2017 | $3,783,796,000 | +7.6% | 44,110,471 | +5.9% | 0.65% | +2.2% |
Q2 2017 | $3,515,027,000 | -26.5% | 41,652,173 | -25.5% | 0.63% | -29.5% |
Q1 2017 | $4,784,382,000 | +5.4% | 55,938,051 | -4.1% | 0.90% | -0.4% |
Q4 2016 | $4,539,215,000 | -20.3% | 58,314,679 | -19.8% | 0.90% | -21.3% |
Q3 2016 | $5,698,151,000 | -19.0% | 72,689,768 | +4.3% | 1.14% | -23.2% |
Q2 2016 | $7,037,548,000 | +0.8% | 69,678,692 | -5.3% | 1.49% | +0.1% |
Q1 2016 | $6,979,312,000 | -5.4% | 73,574,869 | -7.3% | 1.49% | -3.9% |
Q4 2015 | $7,374,699,000 | +4.7% | 79,400,286 | -3.9% | 1.55% | -1.0% |
Q3 2015 | $7,040,287,000 | -4.0% | 82,622,776 | -3.6% | 1.57% | +3.8% |
Q2 2015 | $7,336,441,000 | +12.6% | 85,716,102 | +11.7% | 1.51% | +12.1% |
Q1 2015 | $6,517,736,000 | -0.1% | 76,769,565 | +0.9% | 1.35% | -2.8% |
Q4 2014 | $6,521,196,000 | +19.4% | 76,084,429 | +5.9% | 1.38% | +16.2% |
Q3 2014 | $5,461,361,000 | +2.4% | 71,878,934 | +6.1% | 1.19% | +3.4% |
Q2 2014 | $5,334,755,000 | +4.9% | 67,760,124 | -0.1% | 1.15% | +1.0% |
Q1 2014 | $5,085,303,000 | -50.8% | 67,804,036 | -49.3% | 1.14% | -3.6% |
Q4 2013 | $10,333,052,000 | +121.7% | 133,847,830 | +99.0% | 1.18% | +1.8% |
Q3 2013 | $4,661,572,000 | -46.0% | 67,247,137 | -50.7% | 1.16% | +0.9% |
Q2 2013 | $8,626,684,000 | – | 136,282,512 | – | 1.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |